Neuravi Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Neuravi Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10408
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embotrap revascularization device is a new minimally invasive platform for treating acute ischemic stroke. Neuravi’s initial technology platform addresses acute ischemic stroke. The company is developing clinical data to progress the treatment of stroke. It provides therapies that are based on research into the clot and occlusions causing stroke. It markets its products through its distributors. Neuravi is headquartered in Galway, Ireland.

Neuravi Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neuravi Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Neuravi Raises USD16.5 Million in Venture Financing 10
Neuravi Raises USD21.4 Million in Series B Venture Financing 11
Neuravi Raises US$6.4 Million In Series A Financing 13
Acquisition 14
Codman Neuro Acquires Neuravi 14
Neuravi Ltd – Key Competitors 15
Neuravi Ltd – Key Employees 16
Neuravi Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neuravi Ltd, Medical Equipment, Key Facts 2
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Deals By Market, 2012 to YTD 2018 8
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neuravi Raises USD16.5 Million in Venture Financing 10
Neuravi Raises USD21.4 Million in Series B Venture Financing 11
Neuravi Raises US$6.4 Million In Series A Financing 13
Codman Neuro Acquires Neuravi 14
Neuravi Ltd, Key Competitors 15
Neuravi Ltd, Key Employees 16

List of Figures
Neuravi Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Neuravi Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務情報
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • CNTEE Transelectrica S.A.:発電所・企業SWOT分析
    CNTEE Transelectrica S.A. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • W&T Offshore Inc (WTI):企業の財務・戦略的SWOT分析
    W&T Offshore Inc (WTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • Vedanta Resources Plc:企業の戦略・SWOT・財務情報
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • Novasep Holding SAS-製薬・医療分野:企業M&A・提携分析
    Summary Novasep Holding SAS (Novasep), formerly Groupe Novasep SAS is a pharmaceutical company which offers services in molecule production and purification for life science and chemical industries. The company offers contract manufacturing and development, custom manufacturing, process engineering, …
  • Asahi Kasei Corp (3407):製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Corp (Asahi Kasei), manufactures, and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, adipic acid, polyethylene, polystyrene, functiona …
  • Hydrodec Group Plc (HYR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hydrodec Group Plc (Hydrodec) is an oil and gas company that offers oil refining services. The company produces, markets and distributes transformer oil and naphthenic base oil. It undertakes collection, transportation and processing of used non-PCB and PCB-contaminated naphthenic-based tran …
  • Caldera Health Ltd:製品パイプライン分析
    Summary Caldera Health Ltd (Caldera) is a medical device company that develops prostate cancer diagnostic tools. The company develops prostate cancer diagnostic tools to detect and monitor the cancer disease. It also develops proscanZ and auditor tests based on the enzyme linked immunoassays or ELIS …
  • Approach Resources Inc (AREXQ):企業の財務・戦略的SWOT分析
    Approach Resources Inc (AREXQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Molex LLC:企業のM&A・事業提携・投資動向
    Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Medtronic Plc (MDT):医療機器:M&Aディール及び事業提携情報
    Summary Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vas …
  • M.M.Warburg & Co Kgaa
    M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrel …
  • Approach Resources Inc. (AREX)-石油・ガス分野:企業M&A・提携分析
    Summary Approach Resources Inc. (Approach Resources) is an independent upstream oil and gas company. The company acquires oil and natural gas properties; and explores, develops and produces oil, natural gas and natural gas liquids (NGLs). It focuses on oil and gas reserves in oil shale and tight gas …
  • Drugs for Neglected Diseases initiative-製薬・医療分野:企業M&A・提携分析
    Summary Drugs for Neglected Diseases initiative (DNDi) is a research center that discovers and develops new drugs. The center develops therapeutics for the treatment of various diseases. It offers treatments which include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi also offers products …
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆